Transient and suspension: scalable yet flexible single-use process for multiple AAV serotypes

Watch the video or view the poster to learn about: The scale-up of an AAV manufacturing process from shake flasks to 200 L The comparison between different production media and transfection protocols A robust upstream process suitable for different AAV serotypes

Johanna Viiliäinen has a PhD in Biomedical Science, and 2.5 years industrial experience in large-scale mammalian cell culture, process development, and upstream viral vector production.

Please enter your email to access content Read now